1408334-75-7 Usage
General Description
2-(4-Iodo-1H-pyrazol-1-yl)ethanol is a chemical compound with the molecular formula C6H7IN2O. It is a derivative of pyrazole and contains an iodo group attached to the fourth carbon of the pyrazole ring. 2-(4-Iodo-1H-pyrazol-1-yl)ethanol is often used as a reactant in organic synthesis and chemical research, and it has potential applications in the pharmaceutical and agrochemical industries. Additionally, 2-(4-Iodo-1H-pyrazol-1-yl)ethanol may have biological activity that makes it useful in the development of new drugs or therapies, although further research is needed to fully understand its potential benefits. Overall, this chemical is valuable for its versatility and potential in various fields of science and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1408334-75-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,8,3,3 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1408334-75:
(9*1)+(8*4)+(7*0)+(6*8)+(5*3)+(4*3)+(3*4)+(2*7)+(1*5)=147
147 % 10 = 7
So 1408334-75-7 is a valid CAS Registry Number.
1408334-75-7Relevant articles and documents
AZAINDOLE DERIVATIVE AND USE THEREOF AS FGFR AND C-MET INHIBITOR
-
Paragraph 0117-0118, (2021/05/29)
A series of pyrazolopymidine derivatives, and use thereof in the preparation of a medicament for treating disease associated with FGFR and c-Met. The pyrazolopymidine derivative is a compound represented by formula (I), a tautomer, or a pharmaceutically acceptable salt thereof.
KINASE INHIBITORS
-
Paragraph 0423; 0424, (2015/01/06)
Compounds of formula (I) described herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
KINASE INHIBITORS
-
Page/Page column 92, (2015/01/06)
This invention relates to compounds and compositions that are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract.
